Jpmorgan Chase & Co »

Cadrenal Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Cadrenal Therapeutics (CVKD) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Cadrenal Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cadrenal Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cadrenal Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $103k 7.5k 13.78
2025-03-31 $1.8k 100 17.63

More positions owned by Jpmorgan Chase & Co

Nvidia Corporation Common (NVDA)
Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Meta Platforms Common (META)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Broadcom Common (AVGO)
Alphabet Common (GOOG)
Tesla Common (TSLA)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Vanguard S&p 500 Etf Fund (VOO)
Ishares Core S&p 500 Etf Fund (IVV)
Oracle Corp Common (ORCL)
Abbvie Common (ABBV)

View all positions for Jpmorgan Chase & Co

Top funds holding Cadrenal Therapeutics

Vanguard Group
Citadel Advisors
LPL Financial
Geode Capital Management
Jpmorgan Chase & Co
BlackRock
Advisor Group Holdings
Morgan Stanley
Rockefeller Capital Management
Jones Financial Companies, L.L
Hartland & Co
Harbour Investments
Wells Fargo & Company
UBS Group
Archer Investment Corp

View all funds holding Cadrenal Therapeutics